nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.252	0.463	CbGbCtD
Tinidazole—CYP3A4—Progesterone—uterine cancer	0.167	0.307	CbGbCtD
Tinidazole—CYP3A4—Etoposide—uterine cancer	0.0747	0.137	CbGbCtD
Tinidazole—CYP3A4—Doxorubicin—uterine cancer	0.051	0.0936	CbGbCtD
Tinidazole—Glossitis—Epirubicin—uterine cancer	0.00141	0.0031	CcSEcCtD
Tinidazole—Decreased appetite—Progesterone—uterine cancer	0.00141	0.00309	CcSEcCtD
Tinidazole—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00307	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Progesterone—uterine cancer	0.0014	0.00307	CcSEcCtD
Tinidazole—Fatigue—Progesterone—uterine cancer	0.0014	0.00307	CcSEcCtD
Tinidazole—Constipation—Progesterone—uterine cancer	0.00138	0.00304	CcSEcCtD
Tinidazole—Blood bilirubin increased—Epirubicin—uterine cancer	0.00138	0.00302	CcSEcCtD
Tinidazole—Neutropenia—Etoposide—uterine cancer	0.00136	0.00299	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00294	CcSEcCtD
Tinidazole—Feeling abnormal—Progesterone—uterine cancer	0.00133	0.00293	CcSEcCtD
Tinidazole—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00292	CcSEcCtD
Tinidazole—Gastrointestinal pain—Progesterone—uterine cancer	0.00132	0.00291	CcSEcCtD
Tinidazole—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00289	CcSEcCtD
Tinidazole—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00287	CcSEcCtD
Tinidazole—Glossitis—Doxorubicin—uterine cancer	0.00131	0.00287	CcSEcCtD
Tinidazole—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00287	CcSEcCtD
Tinidazole—Ill-defined disorder—Dactinomycin—uterine cancer	0.0013	0.00286	CcSEcCtD
Tinidazole—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00284	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00129	0.00283	CcSEcCtD
Tinidazole—Urticaria—Progesterone—uterine cancer	0.00129	0.00283	CcSEcCtD
Tinidazole—Abdominal pain—Progesterone—uterine cancer	0.00128	0.00281	CcSEcCtD
Tinidazole—Body temperature increased—Progesterone—uterine cancer	0.00128	0.00281	CcSEcCtD
Tinidazole—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.0028	CcSEcCtD
Tinidazole—Blood bilirubin increased—Doxorubicin—uterine cancer	0.00127	0.0028	CcSEcCtD
Tinidazole—Neuropathy peripheral—Etoposide—uterine cancer	0.00127	0.0028	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00278	CcSEcCtD
Tinidazole—Stomatitis—Etoposide—uterine cancer	0.00127	0.00278	CcSEcCtD
Tinidazole—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00278	CcSEcCtD
Tinidazole—Malaise—Dactinomycin—uterine cancer	0.00126	0.00278	CcSEcCtD
Tinidazole—Salivary hypersecretion—Epirubicin—uterine cancer	0.00126	0.00278	CcSEcCtD
Tinidazole—Leukopenia—Dactinomycin—uterine cancer	0.00126	0.00276	CcSEcCtD
Tinidazole—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00276	CcSEcCtD
Tinidazole—Candida infection—Epirubicin—uterine cancer	0.00124	0.00273	CcSEcCtD
Tinidazole—Blood urea increased—Epirubicin—uterine cancer	0.00123	0.0027	CcSEcCtD
Tinidazole—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00266	CcSEcCtD
Tinidazole—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00264	CcSEcCtD
Tinidazole—Myalgia—Dactinomycin—uterine cancer	0.00119	0.00262	CcSEcCtD
Tinidazole—Hypersensitivity—Progesterone—uterine cancer	0.00119	0.00262	CcSEcCtD
Tinidazole—Coma—Epirubicin—uterine cancer	0.00119	0.00261	CcSEcCtD
Tinidazole—Discomfort—Dactinomycin—uterine cancer	0.00118	0.00259	CcSEcCtD
Tinidazole—Salivary hypersecretion—Doxorubicin—uterine cancer	0.00117	0.00257	CcSEcCtD
Tinidazole—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00256	CcSEcCtD
Tinidazole—Asthenia—Progesterone—uterine cancer	0.00116	0.00255	CcSEcCtD
Tinidazole—Hypoaesthesia—Etoposide—uterine cancer	0.00116	0.00255	CcSEcCtD
Tinidazole—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00255	CcSEcCtD
Tinidazole—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00255	CcSEcCtD
Tinidazole—Urinary tract disorder—Etoposide—uterine cancer	0.00115	0.00253	CcSEcCtD
Tinidazole—Candida infection—Doxorubicin—uterine cancer	0.00115	0.00253	CcSEcCtD
Tinidazole—Pruritus—Progesterone—uterine cancer	0.00115	0.00252	CcSEcCtD
Tinidazole—Urethral disorder—Etoposide—uterine cancer	0.00114	0.00251	CcSEcCtD
Tinidazole—Blood urea increased—Doxorubicin—uterine cancer	0.00114	0.0025	CcSEcCtD
Tinidazole—Thrombocytopenia—Dactinomycin—uterine cancer	0.00112	0.00246	CcSEcCtD
Tinidazole—Diarrhoea—Progesterone—uterine cancer	0.00111	0.00243	CcSEcCtD
Tinidazole—Erythema multiforme—Etoposide—uterine cancer	0.0011	0.00242	CcSEcCtD
Tinidazole—Coma—Doxorubicin—uterine cancer	0.0011	0.00242	CcSEcCtD
Tinidazole—Anorexia—Dactinomycin—uterine cancer	0.00109	0.0024	CcSEcCtD
Tinidazole—Flushing—Etoposide—uterine cancer	0.00108	0.00238	CcSEcCtD
Tinidazole—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00238	CcSEcCtD
Tinidazole—Dizziness—Progesterone—uterine cancer	0.00107	0.00235	CcSEcCtD
Tinidazole—Angiopathy—Etoposide—uterine cancer	0.00106	0.00232	CcSEcCtD
Tinidazole—Immune system disorder—Etoposide—uterine cancer	0.00105	0.00231	CcSEcCtD
Tinidazole—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00231	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00104	0.00229	CcSEcCtD
Tinidazole—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00228	CcSEcCtD
Tinidazole—Vomiting—Progesterone—uterine cancer	0.00103	0.00226	CcSEcCtD
Tinidazole—Rash—Progesterone—uterine cancer	0.00102	0.00224	CcSEcCtD
Tinidazole—Dermatitis—Progesterone—uterine cancer	0.00102	0.00224	CcSEcCtD
Tinidazole—Headache—Progesterone—uterine cancer	0.00101	0.00223	CcSEcCtD
Tinidazole—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00221	CcSEcCtD
Tinidazole—Decreased appetite—Dactinomycin—uterine cancer	0.000995	0.00219	CcSEcCtD
Tinidazole—Dysgeusia—Etoposide—uterine cancer	0.000994	0.00218	CcSEcCtD
Tinidazole—Fatigue—Dactinomycin—uterine cancer	0.000987	0.00217	CcSEcCtD
Tinidazole—Muscle spasms—Etoposide—uterine cancer	0.000976	0.00214	CcSEcCtD
Tinidazole—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00097	0.00213	CcSEcCtD
Tinidazole—Nausea—Progesterone—uterine cancer	0.000962	0.00211	CcSEcCtD
Tinidazole—Feeling abnormal—Dactinomycin—uterine cancer	0.000943	0.00207	CcSEcCtD
Tinidazole—Ill-defined disorder—Etoposide—uterine cancer	0.000942	0.00207	CcSEcCtD
Tinidazole—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000936	0.00206	CcSEcCtD
Tinidazole—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000933	0.00205	CcSEcCtD
Tinidazole—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000925	0.00203	CcSEcCtD
Tinidazole—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000924	0.00203	CcSEcCtD
Tinidazole—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000919	0.00202	CcSEcCtD
Tinidazole—Malaise—Etoposide—uterine cancer	0.000915	0.00201	CcSEcCtD
Tinidazole—Vertigo—Etoposide—uterine cancer	0.000912	0.002	CcSEcCtD
Tinidazole—Leukopenia—Etoposide—uterine cancer	0.000909	0.002	CcSEcCtD
Tinidazole—Body temperature increased—Dactinomycin—uterine cancer	0.000905	0.00199	CcSEcCtD
Tinidazole—Abdominal pain—Dactinomycin—uterine cancer	0.000905	0.00199	CcSEcCtD
Tinidazole—Ataxia—Epirubicin—uterine cancer	0.000888	0.00195	CcSEcCtD
Tinidazole—Convulsion—Etoposide—uterine cancer	0.000879	0.00193	CcSEcCtD
Tinidazole—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000872	0.00191	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000858	0.00189	CcSEcCtD
Tinidazole—Discomfort—Etoposide—uterine cancer	0.000854	0.00188	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000851	0.00187	CcSEcCtD
Tinidazole—Hypersensitivity—Dactinomycin—uterine cancer	0.000843	0.00185	CcSEcCtD
Tinidazole—Confusional state—Etoposide—uterine cancer	0.000835	0.00184	CcSEcCtD
Tinidazole—Ataxia—Doxorubicin—uterine cancer	0.000822	0.00181	CcSEcCtD
Tinidazole—Asthenia—Dactinomycin—uterine cancer	0.000821	0.0018	CcSEcCtD
Tinidazole—Thrombocytopenia—Etoposide—uterine cancer	0.000811	0.00178	CcSEcCtD
Tinidazole—Skin disorder—Etoposide—uterine cancer	0.000805	0.00177	CcSEcCtD
Tinidazole—Hyperhidrosis—Etoposide—uterine cancer	0.000801	0.00176	CcSEcCtD
Tinidazole—Anorexia—Etoposide—uterine cancer	0.00079	0.00173	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000787	0.00173	CcSEcCtD
Tinidazole—Diarrhoea—Dactinomycin—uterine cancer	0.000783	0.00172	CcSEcCtD
Tinidazole—Neutropenia—Epirubicin—uterine cancer	0.000764	0.00168	CcSEcCtD
Tinidazole—Dysuria—Epirubicin—uterine cancer	0.000764	0.00168	CcSEcCtD
Tinidazole—Paraesthesia—Etoposide—uterine cancer	0.000744	0.00163	CcSEcCtD
Tinidazole—Dyspnoea—Etoposide—uterine cancer	0.000739	0.00162	CcSEcCtD
Tinidazole—Somnolence—Etoposide—uterine cancer	0.000736	0.00162	CcSEcCtD
Tinidazole—Drowsiness—Epirubicin—uterine cancer	0.000728	0.0016	CcSEcCtD
Tinidazole—Vomiting—Dactinomycin—uterine cancer	0.000728	0.0016	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000722	0.00159	CcSEcCtD
Tinidazole—Rash—Dactinomycin—uterine cancer	0.000722	0.00159	CcSEcCtD
Tinidazole—Decreased appetite—Etoposide—uterine cancer	0.00072	0.00158	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Etoposide—uterine cancer	0.000715	0.00157	CcSEcCtD
Tinidazole—Fatigue—Etoposide—uterine cancer	0.000714	0.00157	CcSEcCtD
Tinidazole—Neuropathy peripheral—Epirubicin—uterine cancer	0.000714	0.00157	CcSEcCtD
Tinidazole—Stomatitis—Epirubicin—uterine cancer	0.00071	0.00156	CcSEcCtD
Tinidazole—Constipation—Etoposide—uterine cancer	0.000708	0.00156	CcSEcCtD
Tinidazole—Urinary tract infection—Epirubicin—uterine cancer	0.000708	0.00155	CcSEcCtD
Tinidazole—Dysuria—Doxorubicin—uterine cancer	0.000707	0.00155	CcSEcCtD
Tinidazole—Neutropenia—Doxorubicin—uterine cancer	0.000707	0.00155	CcSEcCtD
Tinidazole—Sweating—Epirubicin—uterine cancer	0.000698	0.00153	CcSEcCtD
Tinidazole—Feeling abnormal—Etoposide—uterine cancer	0.000683	0.0015	CcSEcCtD
Tinidazole—Nausea—Dactinomycin—uterine cancer	0.00068	0.00149	CcSEcCtD
Tinidazole—Gastrointestinal pain—Etoposide—uterine cancer	0.000677	0.00149	CcSEcCtD
Tinidazole—Drowsiness—Doxorubicin—uterine cancer	0.000674	0.00148	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000668	0.00147	CcSEcCtD
Tinidazole—Neuropathy peripheral—Doxorubicin—uterine cancer	0.00066	0.00145	CcSEcCtD
Tinidazole—Urticaria—Etoposide—uterine cancer	0.000658	0.00145	CcSEcCtD
Tinidazole—Stomatitis—Doxorubicin—uterine cancer	0.000657	0.00144	CcSEcCtD
Tinidazole—Abdominal pain—Etoposide—uterine cancer	0.000655	0.00144	CcSEcCtD
Tinidazole—Body temperature increased—Etoposide—uterine cancer	0.000655	0.00144	CcSEcCtD
Tinidazole—Urinary tract infection—Doxorubicin—uterine cancer	0.000655	0.00144	CcSEcCtD
Tinidazole—Hypoaesthesia—Epirubicin—uterine cancer	0.00065	0.00143	CcSEcCtD
Tinidazole—Pharyngitis—Epirubicin—uterine cancer	0.000649	0.00143	CcSEcCtD
Tinidazole—Sweating—Doxorubicin—uterine cancer	0.000646	0.00142	CcSEcCtD
Tinidazole—Urinary tract disorder—Epirubicin—uterine cancer	0.000646	0.00142	CcSEcCtD
Tinidazole—Urethral disorder—Epirubicin—uterine cancer	0.000641	0.00141	CcSEcCtD
Tinidazole—Erythema multiforme—Epirubicin—uterine cancer	0.000618	0.00136	CcSEcCtD
Tinidazole—Hypersensitivity—Etoposide—uterine cancer	0.00061	0.00134	CcSEcCtD
Tinidazole—Flushing—Epirubicin—uterine cancer	0.000607	0.00133	CcSEcCtD
Tinidazole—Hypoaesthesia—Doxorubicin—uterine cancer	0.000602	0.00132	CcSEcCtD
Tinidazole—Pharyngitis—Doxorubicin—uterine cancer	0.0006	0.00132	CcSEcCtD
Tinidazole—Urinary tract disorder—Doxorubicin—uterine cancer	0.000597	0.00131	CcSEcCtD
Tinidazole—Asthenia—Etoposide—uterine cancer	0.000594	0.00131	CcSEcCtD
Tinidazole—Angiopathy—Epirubicin—uterine cancer	0.000593	0.0013	CcSEcCtD
Tinidazole—Urethral disorder—Doxorubicin—uterine cancer	0.000593	0.0013	CcSEcCtD
Tinidazole—Immune system disorder—Epirubicin—uterine cancer	0.00059	0.0013	CcSEcCtD
Tinidazole—Pruritus—Etoposide—uterine cancer	0.000586	0.00129	CcSEcCtD
Tinidazole—Erythema multiforme—Doxorubicin—uterine cancer	0.000572	0.00126	CcSEcCtD
Tinidazole—Malnutrition—Epirubicin—uterine cancer	0.000569	0.00125	CcSEcCtD
Tinidazole—Diarrhoea—Etoposide—uterine cancer	0.000567	0.00125	CcSEcCtD
Tinidazole—Flushing—Doxorubicin—uterine cancer	0.000561	0.00123	CcSEcCtD
Tinidazole—Flatulence—Epirubicin—uterine cancer	0.000561	0.00123	CcSEcCtD
Tinidazole—Dysgeusia—Epirubicin—uterine cancer	0.000557	0.00122	CcSEcCtD
Tinidazole—Angiopathy—Doxorubicin—uterine cancer	0.000549	0.00121	CcSEcCtD
Tinidazole—Dizziness—Etoposide—uterine cancer	0.000548	0.0012	CcSEcCtD
Tinidazole—Muscle spasms—Epirubicin—uterine cancer	0.000547	0.0012	CcSEcCtD
Tinidazole—Immune system disorder—Doxorubicin—uterine cancer	0.000546	0.0012	CcSEcCtD
Tinidazole—Ill-defined disorder—Epirubicin—uterine cancer	0.000528	0.00116	CcSEcCtD
Tinidazole—Vomiting—Etoposide—uterine cancer	0.000527	0.00116	CcSEcCtD
Tinidazole—Malnutrition—Doxorubicin—uterine cancer	0.000526	0.00116	CcSEcCtD
Tinidazole—Rash—Etoposide—uterine cancer	0.000522	0.00115	CcSEcCtD
Tinidazole—Dermatitis—Etoposide—uterine cancer	0.000522	0.00115	CcSEcCtD
Tinidazole—Headache—Etoposide—uterine cancer	0.000519	0.00114	CcSEcCtD
Tinidazole—Flatulence—Doxorubicin—uterine cancer	0.000519	0.00114	CcSEcCtD
Tinidazole—Dysgeusia—Doxorubicin—uterine cancer	0.000516	0.00113	CcSEcCtD
Tinidazole—Malaise—Epirubicin—uterine cancer	0.000513	0.00113	CcSEcCtD
Tinidazole—Vertigo—Epirubicin—uterine cancer	0.000511	0.00112	CcSEcCtD
Tinidazole—Leukopenia—Epirubicin—uterine cancer	0.000509	0.00112	CcSEcCtD
Tinidazole—Muscle spasms—Doxorubicin—uterine cancer	0.000506	0.00111	CcSEcCtD
Tinidazole—Palpitations—Epirubicin—uterine cancer	0.000503	0.0011	CcSEcCtD
Tinidazole—Convulsion—Epirubicin—uterine cancer	0.000493	0.00108	CcSEcCtD
Tinidazole—Nausea—Etoposide—uterine cancer	0.000492	0.00108	CcSEcCtD
Tinidazole—Ill-defined disorder—Doxorubicin—uterine cancer	0.000488	0.00107	CcSEcCtD
Tinidazole—Arthralgia—Epirubicin—uterine cancer	0.000484	0.00106	CcSEcCtD
Tinidazole—Myalgia—Epirubicin—uterine cancer	0.000484	0.00106	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000481	0.00106	CcSEcCtD
Tinidazole—Discomfort—Epirubicin—uterine cancer	0.000479	0.00105	CcSEcCtD
Tinidazole—Malaise—Doxorubicin—uterine cancer	0.000475	0.00104	CcSEcCtD
Tinidazole—Vertigo—Doxorubicin—uterine cancer	0.000473	0.00104	CcSEcCtD
Tinidazole—Leukopenia—Doxorubicin—uterine cancer	0.000471	0.00104	CcSEcCtD
Tinidazole—Confusional state—Epirubicin—uterine cancer	0.000468	0.00103	CcSEcCtD
Tinidazole—Palpitations—Doxorubicin—uterine cancer	0.000465	0.00102	CcSEcCtD
Tinidazole—Convulsion—Doxorubicin—uterine cancer	0.000456	0.001	CcSEcCtD
Tinidazole—Nervous system disorder—Epirubicin—uterine cancer	0.000455	0.001	CcSEcCtD
Tinidazole—Thrombocytopenia—Epirubicin—uterine cancer	0.000455	0.000999	CcSEcCtD
Tinidazole—Skin disorder—Epirubicin—uterine cancer	0.000451	0.000991	CcSEcCtD
Tinidazole—Hyperhidrosis—Epirubicin—uterine cancer	0.000449	0.000986	CcSEcCtD
Tinidazole—Myalgia—Doxorubicin—uterine cancer	0.000448	0.000985	CcSEcCtD
Tinidazole—Arthralgia—Doxorubicin—uterine cancer	0.000448	0.000985	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000445	0.000978	CcSEcCtD
Tinidazole—Discomfort—Doxorubicin—uterine cancer	0.000443	0.000973	CcSEcCtD
Tinidazole—Anorexia—Epirubicin—uterine cancer	0.000443	0.000972	CcSEcCtD
Tinidazole—Confusional state—Doxorubicin—uterine cancer	0.000433	0.000952	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000423	0.000929	CcSEcCtD
Tinidazole—Nervous system disorder—Doxorubicin—uterine cancer	0.000421	0.000926	CcSEcCtD
Tinidazole—Thrombocytopenia—Doxorubicin—uterine cancer	0.000421	0.000924	CcSEcCtD
Tinidazole—Insomnia—Epirubicin—uterine cancer	0.00042	0.000923	CcSEcCtD
Tinidazole—Skin disorder—Doxorubicin—uterine cancer	0.000417	0.000917	CcSEcCtD
Tinidazole—Paraesthesia—Epirubicin—uterine cancer	0.000417	0.000916	CcSEcCtD
Tinidazole—Hyperhidrosis—Doxorubicin—uterine cancer	0.000415	0.000913	CcSEcCtD
Tinidazole—Dyspnoea—Epirubicin—uterine cancer	0.000414	0.00091	CcSEcCtD
Tinidazole—Somnolence—Epirubicin—uterine cancer	0.000413	0.000907	CcSEcCtD
Tinidazole—Anorexia—Doxorubicin—uterine cancer	0.00041	0.0009	CcSEcCtD
Tinidazole—Dyspepsia—Epirubicin—uterine cancer	0.000409	0.000898	CcSEcCtD
Tinidazole—Decreased appetite—Epirubicin—uterine cancer	0.000404	0.000887	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000401	0.000881	CcSEcCtD
Tinidazole—Fatigue—Epirubicin—uterine cancer	0.0004	0.00088	CcSEcCtD
Tinidazole—Constipation—Epirubicin—uterine cancer	0.000397	0.000872	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000391	0.00086	CcSEcCtD
Tinidazole—Insomnia—Doxorubicin—uterine cancer	0.000389	0.000854	CcSEcCtD
Tinidazole—Paraesthesia—Doxorubicin—uterine cancer	0.000386	0.000848	CcSEcCtD
Tinidazole—Dyspnoea—Doxorubicin—uterine cancer	0.000383	0.000842	CcSEcCtD
Tinidazole—Feeling abnormal—Epirubicin—uterine cancer	0.000383	0.000841	CcSEcCtD
Tinidazole—Somnolence—Doxorubicin—uterine cancer	0.000382	0.000839	CcSEcCtD
Tinidazole—Gastrointestinal pain—Epirubicin—uterine cancer	0.00038	0.000834	CcSEcCtD
Tinidazole—Dyspepsia—Doxorubicin—uterine cancer	0.000378	0.000831	CcSEcCtD
Tinidazole—Decreased appetite—Doxorubicin—uterine cancer	0.000374	0.000821	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000371	0.000815	CcSEcCtD
Tinidazole—Fatigue—Doxorubicin—uterine cancer	0.00037	0.000814	CcSEcCtD
Tinidazole—Urticaria—Epirubicin—uterine cancer	0.000369	0.00081	CcSEcCtD
Tinidazole—Constipation—Doxorubicin—uterine cancer	0.000367	0.000807	CcSEcCtD
Tinidazole—Abdominal pain—Epirubicin—uterine cancer	0.000367	0.000806	CcSEcCtD
Tinidazole—Body temperature increased—Epirubicin—uterine cancer	0.000367	0.000806	CcSEcCtD
Tinidazole—Feeling abnormal—Doxorubicin—uterine cancer	0.000354	0.000778	CcSEcCtD
Tinidazole—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000351	0.000772	CcSEcCtD
Tinidazole—Hypersensitivity—Epirubicin—uterine cancer	0.000342	0.000752	CcSEcCtD
Tinidazole—Urticaria—Doxorubicin—uterine cancer	0.000341	0.00075	CcSEcCtD
Tinidazole—Body temperature increased—Doxorubicin—uterine cancer	0.00034	0.000746	CcSEcCtD
Tinidazole—Abdominal pain—Doxorubicin—uterine cancer	0.00034	0.000746	CcSEcCtD
Tinidazole—Asthenia—Epirubicin—uterine cancer	0.000333	0.000732	CcSEcCtD
Tinidazole—Pruritus—Epirubicin—uterine cancer	0.000329	0.000722	CcSEcCtD
Tinidazole—Diarrhoea—Epirubicin—uterine cancer	0.000318	0.000698	CcSEcCtD
Tinidazole—Hypersensitivity—Doxorubicin—uterine cancer	0.000317	0.000695	CcSEcCtD
Tinidazole—Asthenia—Doxorubicin—uterine cancer	0.000308	0.000677	CcSEcCtD
Tinidazole—Dizziness—Epirubicin—uterine cancer	0.000307	0.000675	CcSEcCtD
Tinidazole—Pruritus—Doxorubicin—uterine cancer	0.000304	0.000668	CcSEcCtD
Tinidazole—Vomiting—Epirubicin—uterine cancer	0.000295	0.000649	CcSEcCtD
Tinidazole—Diarrhoea—Doxorubicin—uterine cancer	0.000294	0.000646	CcSEcCtD
Tinidazole—Rash—Epirubicin—uterine cancer	0.000293	0.000643	CcSEcCtD
Tinidazole—Dermatitis—Epirubicin—uterine cancer	0.000293	0.000643	CcSEcCtD
Tinidazole—Headache—Epirubicin—uterine cancer	0.000291	0.000639	CcSEcCtD
Tinidazole—Dizziness—Doxorubicin—uterine cancer	0.000284	0.000624	CcSEcCtD
Tinidazole—Nausea—Epirubicin—uterine cancer	0.000276	0.000606	CcSEcCtD
Tinidazole—Vomiting—Doxorubicin—uterine cancer	0.000273	0.0006	CcSEcCtD
Tinidazole—Rash—Doxorubicin—uterine cancer	0.000271	0.000595	CcSEcCtD
Tinidazole—Dermatitis—Doxorubicin—uterine cancer	0.000271	0.000595	CcSEcCtD
Tinidazole—Headache—Doxorubicin—uterine cancer	0.000269	0.000591	CcSEcCtD
Tinidazole—Nausea—Doxorubicin—uterine cancer	0.000255	0.000561	CcSEcCtD
